Details of the Drug Reposition

General Information of This Drug (ID: DMWS3FH)

Drug Name
Fondaparinux sodium   DMWS3FH
Synonyms Arixtra; Quixidar; Fondaparin sodium; Arixtra (TN); GSK-576428; SR-90107; SR-90107A; Fondaparinux sodium (JAN/USAN/INN)
Therapeutic Class
Anticoagulants
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Myocardial infarction DIS655KI BA41-BA43 Approved [1]
Deep vein thrombosis DISD8N1U BD71 Approved [1]
------------------------------------------------------------------------------------
1 Withdrawn Indication(s)
Indication Name Indication ID ICD-11 Status REF
Ovarian cancer DISZJHAP 2C73 Withdrawn [2]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Venous thrombosis DISVHK7H BA43 Investigative [3]
------------------------------------------------------------------------------------

References

1 Fondaparinux sodium FDA Label
2 ClinicalTrials.gov (NCT00000372) Glycine and D-Cycloserine in Schizophrenia
3 Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.